# Haemonetics Corp: Form 8-K, filed Mar 3, 2026

- Company: [Haemonetics Corp](/companies/hae.md) (CIK 313143)
- Form: 8-K
- Filed: 2026-03-03
- Accepted by EDGAR: Mar 3, 2026, 06:09 ET
- Period: 2026-03-03
- Accession: 0000313143-26-000017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313143/000031314326000017/hae-20260303.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313143/000031314326000017/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/313143/000031314326000017/hae-20260303.htm

Filed Mar 3, 2026.
Source: SEC EDGAR, the filing index for accession 0000313143-26-000017. Last ingested by Listed: Nov 12, 2026, 18:11 ET. No prices; not investment advice.
